The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s
Abstract
We analyze the effect of price regulation on delays in launch of new drugs. Because a low price in one market may ‘spill‐over’ to other markets, through parallel trade and external referencing, manufacturers may rationally prefer longer delay or non‐launch to accepting a relatively low price. We analyze the launch in 25 major markets, including 14 EU countries, of 85 new chemical entities (NCEs) launched between 1994 and 1998. Each NCE's expected price and market size in a country are estimated using lagged average price and market size of other drugs in the same (or related) therapeutic class. We estimate a Cox proportional hazard model of launch in each country, relative to first global launch. Only 55% of the potential launches occur. The US leads with 73 launches, followed by Germany (66) and the UK (64). Only 13 NCEs are launched in Japan, 26 in Portugal and 28 in New Zealand. The results indicate that countries with lower expected prices or smaller expected market size have fewer launches and longer launch delays, controlling for per capita income and other country and firm characteristics. Controlling for expected price and volume, country effects for the likely parallel export countries are significantly negative. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments
Peltzman, S. (1973) · Journal of Political Economy · doi:10.1086/260107 · Cited by 367
Cited by
Pharmaceutical Price Controls and Entry Strategies
Kyle, M. K. (2007) · Review of Economics and Statistics · doi:10.1162/rest.89.1.88 · Cited by 297
Evaluating the administration costs of biologic drugs: development of a cost algorithm
Tetteh, E. K., & Morris, S. (2014) · Health Economics Review · doi:10.1186/s13561-014-0026-2 · Cited by 34
Metadata
- Authors
- Danzon, P. M., Wang, Y. R., & Wang, L.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2004-09-02
- Volume
- 14
- Issue
- 3
- Pages
- 269-292
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2891211072
- Cited by
- 343
- References
- 1
- FWCI
- 39.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s. https://app.cochat.ai/papers/10.1002/hec.931
- The paper
- Danzon, P. M., Wang, Y. R., & Wang, L. (2005). The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s. Health Economics. https://doi.org/10.1002/hec.931
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.